Simon Coates, Oliver Pohl, Jean-Pierre Gotteland, Jörg Täubel, Ulrike Lorch
Article first published online: January 27, 2019
Simon Coates, Oliver Pohl, Jean-Pierre Gotteland, Jörg Täubel, Ulrike Lorch
Article first published online: January 27, 2019
Geneva, Switzerland and Boston, MA – January 23, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization…
Geneva, Switzerland and Boston, MA – January 23, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization…
Member
ObsEva Board of Directors
Partner, NEA (U.S.A.)Member, ObsEva Board of Directors
Audit Committee Chair
ObsEva Board of Directors
Member
ObsEva Board of Directors
Co-Founder & CEO – ObsEvaMember, ObsEva Board of Directors
Co-Founder / Interim Chairman
ObsEva Board of Directors
Geneva, Switzerland and Boston – January 2, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of…